期刊文献+

抑郁症动物模型研究进展 被引量:38

Resentprogress in the research of depressive animal model
下载PDF
导出
摘要 抑郁症临床上可单发或继发于脑卒中等疾病之后,由于其发病机制至今尚未完全清楚,给抑郁症动物模型的研制带来很大的困难。应激动物模型,神经生化功能改变模型及孤养和分养模型等是目前常用的动物模型,但只表现出抑郁症的某些方面症状。转基因动物模型是一类很有希望的动物模型,能够比较全面地表现出抑郁症症状,逐渐成为抑郁症动物模型研究的热点。
出处 《中国临床康复》 CSCD 2004年第10期1932-1933,共2页 Chinese Journal of Clinical Rehabilitation
基金 国家科技部重点科技项目(攻关)计划(96-901-06-75)
  • 相关文献

参考文献55

  • 1陈小江,林志雄,李君良,邹晓波.抗抑郁药物对脑卒中后抑郁症及其神经功能康复疗效观察[J].中国临床康复,2002,6(9):1289-1289. 被引量:7
  • 2Porsolt RD, Bertin A, Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur Pharmacol 1978; 51 (3):291 -4.
  • 3Schmidt J, Nootropic. Drugs reduce immobility in behavioural despair test in mice. Biomed Biochim Acta 1984; 43 ( 11 ) : 1295 - 9.
  • 4Steru L, Chemmt R. Thierry B, et al. The tail suspesion test: A new method for screening antidepressants in mice. Psychopharmacology 1985; 85 (3) : 367 - 70.
  • 5Willner P. Validation criteria for animal models of human mental disorders:Learned helplessness as a paradigm ease. Psychopharmacology 1985; 85(4):387 - 404.
  • 6Roth KA, Katz RJ. Futher studies on a novel animal model of depression: Therapeutic effects of a tricyclic antidepressant. Neurosci Biobehav Rev 1981; 5(2):253 - 8.
  • 7Katz R J, Baldrighi G. A further parametric study of imipramine in an animal model of depression. Pharmacol Biochem Behav 1982; 169(6): 969 -72.
  • 8Muscat TR, Papp M, Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 1992;109(4): 433 - 8.
  • 9Bertmar G, Tort R. Sensor,' mechanisms of homing in Salmonid fish.Ⅰ. Introductory experiments on the olfactory sense in grilse of Baltic salmon(Salmosalar). Behaviour 1969; 35(3): 235 -41.
  • 10Burkard WP, Bonetri EP, Prada MD, et al. Phamaacolofical profile of moclobemide, a short cting and reversible inhibitor of monamine oxidase type A. Pharmacol Exp Ther 1989;248(1):391 -9.

二级参考文献7

  • 1李根华.脑卒中后的抑郁症[J].国外医学(脑血管疾病分册),1996,4(1):22-24. 被引量:156
  • 2张明圆.精神科评定量表手册(第2版)[M].长沙:湖南科学技术出版社,1998,10.39-42,133-136.
  • 3[1]GOWER AJ, BREKKAMP CL, RIJK HW, et al. Pharmacological evaluation of in vivo test for α 2 adrenoceptor blacade in the central nervous system and the effects of the enantionmers of mianserin and its aza analog Org 3770[J].Arch Int Pharmacodyn, 1988, 291: 185-201.
  • 4[3]BLEHAR MC. Family and genetic studies of affective disorders[J]. Arch Gen Psychiat, 1988,45: 289-292.
  • 5[4]ARYA D.Extrapyramidal symptoms with SSRIs[J]. Br J Psychiatry, 1994,165: 728-733.
  • 6[5]PALAZIDOU E, PAPADOPOULOS A.An α2 adrenoceptor antagonist, mitazapine enhances nocturnal melatonin secretion in man[J]. Psychopharmacol,1989, 97: 115-117.
  • 7喻东山.抑郁症和去甲肾上腺素能受体[J].国际精神病学杂志,1989,31(4):218-222. 被引量:2

共引文献13

同被引文献371

引证文献38

二级引证文献422

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部